August 25, 2010
Bioniche & University of Ottawa Sign Exclusive Global License Agreement for Natural Health Technology

August 20, 2010
Additional Phase III Clinical Trial with UrocidinTM Expected to Commence in 2010

Check latest
stock price

All prices delayed at least 15 minutes.
Source: TSX Inc.

For your convenience, you can download printable versions of the following Bioniche corporate publications in PDF format. To request copies by mail, please contact corporatecommunications@bioniche.com or call (613) 966-8058 ext. 1250.

Fiscal 2010

Second Quarter Report

First Quarter Report

Fiscal 2009 Annual Report 2009 Third Quarter Report Second Quarter Report First Quarter Report Fiscal 2008 2008 Annual Information Form Annual Report 2008 Third Quarter Report Second Quarter Report First Quarter Report Fiscal 2007 2007 Annual Information Form Annual Report 2007 Third Quarter Report Second Quarter Report First Quarter Report Fiscal 2006 2006 Annual Information Form Annual Report 2006 Third Quarter Report Second Quarter Report First Quarter Report Fiscal 2005 2005 Annual Information Form Annual Report 2005 Third Quarter Report Second Quarter Report First Quarter Report

Fiscal 2004 2004 Annual Information Form Annual Report 2004 Third Quarter Report Second Quarter Report First Quarter Report

Fiscal 2003

Annual Report 2003 Complete report Letter to shareholders Management's discussion and analysis Consolidated financial statements and notes Third Quarter Report Second Quarter Report First Quarter Report

2006 Annual Information Form 2005 Annual Information Form 2004 Annual Information Form 2003 Annual Information Form View all Bioniche publicly-listed documents here